Menu
Lucrosus Capital

Lucrosus Capital (LUCA)

Last update of this project: 17.02.2022

ICO QUALITY

Main info:
10
Finance:
8.8
Product:
6.6
Team:
5.0
Marketing:
8.2
7.7? ICO score Lucrosus Capital
By investing in this ICO you agree to our Disclaimer
Rate this project: or send report:

SUMMARY

Type: ICO
Category: Finance
Verified team: No
Whitelist of investors: No
KYC of investors: No
Goal of funding: 1 000 000 USD
Tokens for sale: 1 000 000 000 LUCA
Token price: 1 LUCA = 0.00115 USD
Airdrop program: No
Bounty program: No
Have escrow agent: No
Have working prototype: No
White paper: Open
Currencies: USD, EURO, BTC, ETH, BNB, SOL, LUNA, LTC, TRX, MATIC, USDT, USDC, BUSD, UST, BCH, DAI
Type: Utility token
Location: Cyprus
Website: https://www.lucrosus.capital
Links:

DESCRIPTION

Lucrosus Capital is a Decentralized Venture Capital focused on the cryptocurrency industry. Our goal is to redefine the concept of investing by implementing all of the beneficial blockchain features to venture capital. DeVC provides institutional benefits to individual investors. To attract investors to $LUCA we are developing many utilities such as shared allocation program, buy-back program, governance, staking, access to highly advanced research, and One-on-One with projects’ representatives.

FUNDING INFORMATION

Start time
2022 Jan 17th
1
1
:
0
0
:
0
0
End time
2022 Apr 17th
1
1
:
0
0
:
0
0
Percentage of completion
100%
Distribution
Public Sale 55.00%
Private Sale 5.00%
Development 8.00%
Liquidity 4.00%
Team 9.00%
Marketing 8.00%
Advisors 8.00%
Airdrop 3.00%

MEDIA

Presentation
Latest tweets

ROADMAP

Q1 2019 Creating the concept of Lucrosus Capital.

Q4 2020 Development of our cutting-edge algorithm.

Q1 2021 Implementation and testing the algorithm.

Q1 2021 Public Sale starts.

Q2 2021 Establishment of the core team.

Q2 2021 The launch of buy-back and shared allocation program.

Q3 2021 Private sale starts, back-end project.

Q3 2021 The launch of staking and voting programs.

Q4 2021 First Lucrosus Capital investments roll in.

Q4 2021 The launch of the Lucrosus Academy and the Lucrosus Incubator.

TEAM

Peter Barbachowski

CEO & Founder

John Różycki

COO  

ADVISORS

Christopher Pietkun

Strategy Advisor

Miroslaw Barszcz

Investor Relations Officer

Piotr Jeżółkowski

Chief Legal Officer

STATISTICS

Twitter
Telegram

SIMILAR ICO

ELEVATED NATION ELEVATED NATION (ICO) Date is TBA Finance 3.8
ELEVATED NATION ELEVATED NATION
At **Elevated Nation**, we are not just a company; we are a community, a mindset, and a way of life....
MATCH MATCH (Pre-ICO) Date is TBA Finance 5.5
MATCH MATCH
MATCH is a utility token for the De-Fi in a form of liquidity staking and Decentralized Bet (De-Bet)...
ZircuitDEX ZircuitDEX (ICO) Date is TBA Finance 4.9
ZircuitDEX ZircuitDEX
ZDEX is the native governance and utility token of ZircuitDEX, the hottest DEX on the blazing-fast Z...
Cutoshi Cutoshi (Pre-ICO) Date is TBA Finance 4.4
Cutoshi Cutoshi
Cutoshi is a revolutionary meme coin on a mission to bring prosperity and wealth to its holders. $CU...
STREAMCOIN STREAMCOIN (ICO) Date is TBA Finance 6.4
STREAMCOIN STREAMCOIN
StreamCoin (STRM) is a governance token built on the Binance Smart Chain (BSC) using the BEP-20 toke...
GKASH GKASH (Pre-ICO) Date is TBA Finance 3.3
GKASH GKASH
A good and start-up investment token
RCO Finance 2nd Stage RCO Finance 2nd Stage (Pre-ICO) Date is TBA Finance 3.8
RCO Finance 2nd Stage RCO Finance 2nd Stage
[PRESALE STAGE: 2] RCO Finance (RCOF) RCO Finance is a trading platform for crypto that empowers tr...
IZIChain IZIChain (ICO) Date is TBA Finance 6.0
IZIChain IZIChain
IZIChain is a Public Hybrid Blockchain hyperlink platform providing blockchain custom solutions for ...
BlossomChain BlossomChain (ICO) Date is TBA Finance 5.5
BlossomChain BlossomChain
Swap, earn, and build on the fastest growing decentralized BSC based cryptocurrency trading protocol...
Paradox Coin Paradox Coin (Pre-ICO) Date is TBA Finance Full info 5.1
Paradox Coin Paradox Coin
dex , borrowing and lending , yield farming , liquid mining Full info

COMMENTS

By using this site you agree to the Privacy Policy.